These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22343384)

  • 41. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
    Eggener SE; Carver BS; Sharp DS; Motzer RJ; Bosl GJ; Sheinfeld J
    J Urol; 2007 Mar; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metastatic pathways of nonseminomatous germ cell tumors.
    Donohue JP
    Semin Urol; 1984 Nov; 2(4):217-29. PubMed ID: 6095396
    [No Abstract]   [Full Text] [Related]  

  • 43. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
    De Jong J; Weeda S; Gillis AJ; Oosterhuis JW; Looijenga LH
    Oncol Rep; 2007 Jul; 18(1):127-32. PubMed ID: 17549357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status.
    Bhayani SB; Allaf ME; Kavoussi LR
    Urol Oncol; 2004; 22(2):145-8. PubMed ID: 15082014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
    Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
    Cooper DE; L'esperance JO; Christman MS; Auge BK
    J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
    Delgado R; Rathi A; Albores-Saavedra J; Gazdar AF
    Cancer; 1999 Nov; 86(9):1802-11. PubMed ID: 10547554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB; Steele GS; Richie JP
    J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
    Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
    Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
    Yoon GH; Stein JP; Skinner DG
    Urol Oncol; 2005; 23(3):168-77. PubMed ID: 15907716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surveillance programs for stage I nonseminomatous germ cell tumors of the testis.
    Segal R
    Urol Oncol; 2006; 24(1):68-74. PubMed ID: 16414498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relapses of malignant nonseminomatous germinal testicular tumors].
    Piot G; Droz JP; Caillaud JM; Bellet D; Wibault P; Brulé G; Amiel JL
    J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
    Jacqmin D
    Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
    [No Abstract]   [Full Text] [Related]  

  • 57. Testicular germ cell tumors in patients with human immunodeficiency virus infection.
    Hentrich MU; Brack NG; Schmid P; Schuster T; Clemm C; Hartenstein RC
    Cancer; 1996 May; 77(10):2109-16. PubMed ID: 8640678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors.
    Nguyen CT; Stephenson AJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
    Culine S
    Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.